31
Views
65
CrossRef citations to date
0
Altmetric
Research Article

Clinical Management of the Phencyclidine Psychosis

&
Pages 539-545 | Published online: 25 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (18)

John Stirling & Lauren McCoy. (2010) Quantifying the Psychological Effects of Ketamine: From Euphoria to the k-Hole. Substance Use & Misuse 45:14, pages 2428-2443.
Read now
Howard B. Moss & Ralph E. Tarter. (1993) Substance Abuse, Aggression, and Violence: What Are the Connections ?: Clinical Update. American Journal on Addictions 2:2, pages 149-160.
Read now
Roderick A. Borrie. (1991) The Use of Restricted Environmental Stimulation Therapy in Treating Addictive Behaviors. International Journal of the Addictions 25:sup7, pages 995-1015.
Read now
MichaelM. Miller & RonaldT. Potter-Efron. (1990) Aggression and Violence Associated with Substance Abuse. Journal of Chemical Dependency Treatment 3:1, pages 1-35.
Read now
Thomas Young, Gary W. Lawson & Carl B. Gacono. (1987) Clinical Aspects of Phencyclidine (PCP). International Journal of the Addictions 22:1, pages 1-15.
Read now
George M. Simpson, Ali M. Khajawall, E. Alatorre & F. R. Staples. (1982) Urinary Phencyclidine Excretion in Chronic Abusers. Journal of Toxicology: Clinical Toxicology 19:10, pages 1051-1059.
Read now
Betty L. Davis. (1982) The PCP Epidemic: A Critical Review. International Journal of the Addictions 17:7, pages 1137-1155.
Read now
Orm Aniline & Ferris N. Pitts. (1982) Phencyclidine (PCP): A Review and Perspectives. CRC Critical Reviews in Toxicology 10:2, pages 145-177.
Read now
Ali M. Khajawall & George M. Simpson. (1981) Characteristics of Chronic Phencyclidine Abusers. The American Journal of Drug and Alcohol Abuse 8:3, pages 301-310.
Read now
MichaelA. Fauman & BeverlyJ. Fauman. (1980) Chronic Phencyclidine (PCP) Abuse: A Psychiatric Perspective. Journal of Psychedelic Drugs 12:3-4, pages 307-315.
Read now
DavidE. Smith & DonaldR. Wesson. (1980) PCP Abuse: Diagnostic and Psychopharmacological Treatment Approaches. Journal of Psychedelic Drugs 12:3-4, pages 293-299.
Read now
Regine Aronow, JosephN. Miceli & AlanK. Done. (1980) A Therapeutic Approach to the Acutely Overdosed Patient. Journal of Psychedelic Drugs 12:3-4, pages 259-267.
Read now
RichardE. Garey. (1979) PCP (Phencyclidine): An Update. Journal of Psychedelic Drugs 11:4, pages 265-275.
Read now
George Goldstein, Bruce Levy & Leslie Prichep. (1979) Angel Dust Use in an Outpatient Setting-Clinical Profile and Implications for Treatment. The American Journal of Drug and Alcohol Abuse 6:2, pages 163-172.
Read now
G. G. de Angelis & E. Goldstein. (1978) Treatment of Adolescent Phencyclidine (PCP) Abusers. The American Journal of Drug and Alcohol Abuse 5:4, pages 399-414.
Read now
RobertL. Balster & RoxanneS. Pross. (1978) PHENCYCLIDINE: A Bibliography of Biomedical and Behavioral Research. Journal of Psychedelic Drugs 10:1, pages 1-15.
Read now
RichardE. Garey, LeonA. Weisberg & RobertG. Heath. (1977) Phencyclidine: An Overview. Journal of Psychedelic Drugs 9:4, pages 280-285.
Read now
R. Stanley Burns & Steven E. Lerner. (1976) Perspectives. Clinical Toxicology 9:4, pages 477-501.
Read now

Articles from other publishers (47)

Franciele Kich Giongo, Matheus Gallas-Lopes, Radharani Benvenutti, Adrieli Sachett, Leonardo Marensi Bastos, Adriane Ribeiro Rosa & Ana Paula Herrmann. (2023) Effects of Taurine in Mice and Zebrafish Behavioral Assays With Translational Relevance to Schizophrenia. International Journal of Neuropsychopharmacology 26:2, pages 125-136.
Crossref
Sohei Kimoto, Manabu Makinodan & Toshifumi Kishimoto. (2019) Neurobiology and treatment of social cognition in schizophrenia: Bridging the bed-bench gap. Neurobiology of Disease 131, pages 104315.
Crossref
Thomas GeschwindeThomas Geschwinde. 2018. Rauschdrogen. Rauschdrogen 1 392 .
Thomas GeschwindeThomas Geschwinde. 2013. Rauschdrogen. Rauschdrogen 1 320 .
Vibeke S. Catts & Stanley V. Catts. 2011. Secondary Schizophrenia. Secondary Schizophrenia 141 168 .
A. Fornito, M. Yucel, B. Dean, S. J. Wood & C. Pantelis. (2008) Anatomical Abnormalities of the Anterior Cingulate Cortex in Schizophrenia: Bridging the Gap Between Neuroimaging and Neuropathology. Schizophrenia Bulletin 35:5, pages 973-993.
Crossref
. 2007. Rauschdrogen. Rauschdrogen 7 294 .
John G Csernansky, Maureen Martin, Renu Shah, Amy Bertchume, Jenny Colvin & Hongxin Dong. (2005) Cholinesterase Inhibitors Ameliorate Behavioral Deficits Induced by MK-801 in Mice. Neuropsychopharmacology 30:12, pages 2135-2143.
Crossref
Shuzo Abe, Toshihito Suzuki, Kenichi Endo, Takafumi Hori & Heii Arai. (2005) Effects of single and repeated phencyclidine administration on [3H]flunitrazepam binding in rat brain. Progress in Neuro-Psychopharmacology and Biological Psychiatry 29:1, pages 133-140.
Crossref
Krystyna Ossowska. 2005. Dopamine and Glutamate in Psychiatric Disorders. Dopamine and Glutamate in Psychiatric Disorders 117 149 .
Ales Stuchlik, Lenka Rezacova, Karel Vales, Vera Bubenikova & Stepan Kubik. (2004) Application of a novel Active Allothetic Place Avoidance task (AAPA) in testing a pharmacological model of psychosis in rats: comparison with the Morris Water Maze. Neuroscience Letters 366:2, pages 162-166.
Crossref
Thomas GeschwindeThomas Geschwinde. 2003. Rauschdrogen. Rauschdrogen 7 242 .
Robert M. Moriarty, Livia A. Enache, Lei Zhao, Richard Gilardi, Mariena V. Mattson & Om Prakash. (1998) Rigid Phencyclidine Analogues. Binding to the Phencyclidine and σ 1 Receptors . Journal of Medicinal Chemistry 41:4, pages 468-477.
Crossref
Stuart P. Taylor & Michael R. Hulsizer. 1998. Human Aggression. Human Aggression 139 165 .
Rhea E. Steinpreis. (1996) The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis. Behavioural Brain Research 74:1-2, pages 45-55.
Crossref
Y. Noda, K. Yamada, H. Furukawa & T. Nabeshima. (2012) Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia. British Journal of Pharmacology 116:5, pages 2531-2537.
Crossref
Gaylord Ellison. (1995) The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Research Reviews 20:2, pages 250-267.
Crossref
Howard B. Moss, Ihsan M. Salloum & Barry Fisher. 1994. Handbook of Aggressive and Destructive Behavior in Psychiatric Patients. Handbook of Aggressive and Destructive Behavior in Psychiatric Patients 175 201 .
Xue-Min Gao, Osamu Shirakawa, Fu Du & Carol A. Tamminga. (1993) Delayed regional metabolic actions of phencyclidine. European Journal of Pharmacology 241:1, pages 7-15.
Crossref
Howard B. Moss & Ralph E. Tarter. (2010) Substance Abuse, Aggression, and Violence. The American Journal on Addictions 2:2, pages 149-160.
Crossref
Arthur D. Weissman, Manuel F. Casanova, Joel E. Kleinman, Edythe D. London & Errol B. De Souza. (1991) Selective loss of cerebral cortical Sigma, but not PCP binding sites in schizophrenia. Biological Psychiatry 29:1, pages 41-54.
Crossref
Jerrold B. Leikin, Anne J. Krantz, Michele Zell-Kanter, Robert L. Barkin & Daniel O. Hryhorczuk. (2012) Clinical Features and Management of Intoxication Due to Hallucinogenic Drugs. Medical Toxicology and Adverse Drug Experience 4:5, pages 324-350.
Crossref
A.D. Weissman, Karen L. Marquis, J.E. Moreton & Edythe D. London. (1989) Effects of self-administered phencyclidine on regional uptake of 2-deoxy-d-[1-14C]glucose in brain. Neuropharmacology 28:6, pages 575-583.
Crossref
Thomas R. Kosten & Herbert D. Kleber. (1988) Differential diagnosis of psychiatric comorbidity in substance abusers. Journal of Substance Abuse Treatment 5:4, pages 201-206.
Crossref
Arthur D. Weissman, Mauro Dam & Edythe D. London. (1987) Alterations in local cerebral glucose utilization induced by phencyclidine. Brain Research 435:1-2, pages 29-40.
Crossref
Aviva Gamliel, Gabriel Schreiber & Asher Shainberg. (1987) Synergistic inhibition by trifluoperazine and phencyclidine of carbamylcholine-induced cation influx in muscle cultures. Biochemical Pharmacology 36:14, pages 2271-2277.
Crossref
Ming-Cheng Tsai & Mai-Lei Chen. (1987) Effect of phencyclidine of post-tetanic twitch tension of the mouse diaphragm preparation. Life Sciences 40:23, pages 2229-2236.
Crossref
Claudia Schmauss & Hinderk M. Emrich. (1985) Dopamine and the action of opiates: A reevaluation of the dopamine hypothesis of schizophrenia with special consideration of the role of endogenous opioids in the pathogenesis of schizophrenia. Biological Psychiatry 20:11, pages 1211-1231.
Crossref
B.D. Greenberg, D.S. Segal & B.L. Jacobs. 1985. Preclinical Psychopharmacology. Preclinical Psychopharmacology 343 363 .
Edwin Robbins, Steven B. Katz & Marvin Stern. 1985. Substance Abuse and Psychopathology. Substance Abuse and Psychopathology 239 288 .
Sachin N. Pradhan. (1984) Phencyclidine (PCP): Some human studies. Neuroscience & Biobehavioral Reviews 8:4, pages 493-501.
Crossref
G.C. Haggerty, R.B. Forney & J.M. Johnson. (1984) The effect of a single administration of phencyclidine on behavior in the rat over a 21-day period. Toxicology and Applied Pharmacology 75:3, pages 444-453.
Crossref
Sakti P. Bagchi. (1983) Differential interactions of phencyclidine with tetrabenazine and reserpine affecting intraneuronal dopamine. Biochemical Pharmacology 32:19, pages 2851-2856.
Crossref
Phillip T. Griffin, Richard E. Garey, George C. Daul & John W. Goethe. (2016) Sex and Race Differences in Psychiatric Symptomatology in Phencyclidine Psychosis. Psychological Reports 52:1, pages 263-266.
Crossref
Michael P. Holsapple, Albert E. Munson, Arthur S. Freeman & Billy R. Martin. (1982) Pharmacological activity and toxicity of Phencyclidine (PCP) and Phenylcyclohexene (PC), a pyrolysis product. Life Sciences 31:8, pages 803-813.
Crossref
R. Freedman, D. Kirch, J. Bell, L. E. Adler, M. Pecevich, E. Pachtman & P. Denver. (2007) Clonidine treatment of schizophrenia. Acta Psychiatrica Scandinavica 65:1, pages 35-45.
Crossref
R.David Sturgeon, Richard G. Fessler, Scott F. London & Herbert Y. Meltzer. (1981) A comparison of the effects of neuroleptics on phencyclidine-induced behaviors in the rat. European Journal of Pharmacology 76:1, pages 37-53.
Crossref
Karl Verebey, Michael J. Kogan & S. Joseph Mule. (1981) Phencyclidine-induced stereotypy in rats: Effects of methadone, apomorphine, and naloxone. Psychopharmacology 75:1, pages 44-47.
Crossref
David W. Beaudry & James E. Lennon. (1980) Angel dust: Implications for child care agencies. Child Care Quarterly 9:4, pages 258-264.
Crossref
William J. Freed, Daniel R. Weinberger, Lloyd A. Bing & Richard Jed Wyatt. (1980) Neuropharmacological studies of phencyclidine (PCP)-induced behavioral stimulation in mice. Psychopharmacology 71:3, pages 291-297.
Crossref
Z. E. HeveranM. AnthonyC. Ward. (1980) Determination of Phencyclidine by Radioimmunoassay. Journal of Forensic Sciences 25:1, pages 10940J.
Crossref
M. Krishna Menon, William G. Clark & Charlotte Vivonia. (1980) Interaction between phencyclidine (PCP) and Gaba-ergic drugs: Clinical implications. Pharmacology Biochemistry and Behavior 12:1, pages 113-117.
Crossref
R.E. Garey, S. McQuitty, D. Tootle & R.G. Heath. (1980) The effects of apomorphine and haldol on PCP induced behavioral and motor abnormalities in the rat. Life Sciences 26:4, pages 277-284.
Crossref
Mark L. Richards, Paul J. Perry & Barry I. Liskow. (2016) Phencyclidine Psychosis. Drug Intelligence & Clinical Pharmacy 13:6, pages 336-339.
Crossref
Thomas F. Murray & Akira Horita. (1979) Phencyclidine-induced stereotyped behavior in rats: Dose response effects and antagonism by neuroleptics. Life Sciences 24:24, pages 2217-2225.
Crossref
R.Francis SchlemmerJr.Jr., J.Alan Jackson, Kenzie L. Preston, John P. BederkaJr.Jr., David L. Garver & John M. Davis. (1978) Phencyclidine-induced stereotyped behavior in monkeys: Antagonism by pimozide. European Journal of Pharmacology 52:3-4, pages 379-384.
Crossref
Robert L. Balster & Larry D. Chait. (1978) The effects of phencyclidine on amphetamine stereotypy in rats. European Journal of Pharmacology 48:4, pages 445-450.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.